- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05876520
Clinical and Radiographic Assessment of Nano-Bioactive Glass Combined With I-PRF Scaffold in Vital Pulp Treatments in Mandibular Molars With Closed Apices (I-PRF)
May 24, 2023 updated by: Noor Mohammed Kamal Eldeen Ahmed Mohmammed Sayed, Cairo University
Clinical and Radiographic Assessment of Nano-Bioactive Glass Combined With I-PRF Scaffold in Vital Pulp Treatments in Mandibular Molars With Closed Apices: A Triple Blinded "Randomized Controlled Trial"
Clinical, Radiographic and pain assessment of Vital pulp treatment in patients suffering from irreversible pulpitis in mature permanent molars.
Total pulpotomy is investigated using I-prf only vs I-prf mixed with Nano-bioactive glass.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
28
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Noor K. Sayed
- Phone Number: 00201121818177
- Email: noor.kamal@dentistry.cu.edu.eg
Study Contact Backup
- Name: Kamal K. Ahmed
- Phone Number: 0020 101 4147393
- Email: noor.m.kamal35@gmail.com
Study Locations
-
-
-
Cairo, Egypt
- Recruiting
- Noor Mohammed Kamal Eldeen
-
Contact:
- Noor K. Sayed
- Phone Number: 00201121818177
- Email: noor.kamal@dentistry.cu.edu.eg
-
Contact:
- Noor K. Sayed
- Phone Number: 00201121818177
- Email: noor.m.kamal35@gmail.com
-
Principal Investigator:
- Noor K. Sayed, BDS
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Patients suffering from Symptomatic irreversible pulpitis in mature mandibular molars only will be involved.
- Tooth should give positive response to cold test
- Haemostasias should be achieved after total pulpotomy
- The tooth is restorable and free from advanced periodontal disease, cracks and splits.
- Patients should be free from any systemic disease that may affect normal healing and predictable outcome.
- Patients who will agree to the consent and will commit to follow-up period.
- Patients with mature root apices
- Patients with no internal or external resorption and no periapical lesions
- Soft tissues around the tooth are normal with no swelling or sinus tract.
Exclusion Criteria:
- Patients with immature roots.
- Haemostasias after 10 minutes can not be controlled after total pulpotomy
- Patients with any systemic disease that may affect normal healing.
- Patients with periapical lesions or infections.
- Pregnant females.
- Patients who could/would not participate in a 6 months follow-up.
- Patients with fistula or swelling
- Patients with necrotic pulp.
- Patients with old age.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Total pulpotomy with I-PRF only
Total pulpotomy is done in mature permanent molars followed by I-prf application.
Topped with BC putty for coronal seal, RMGI and restored with composite as final restoration
|
Total pulpotomy is done in mature permanent molars followed by I-prf mixed with Nano-Bioactive glass application.
Topped with BC putty for coronal seal, RMGI and restored with composite as final restoration
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinical , Radiographic and Success rate
Time Frame: 6 month follow up
|
Presence or absence of clinical signs and symptoms + Radiographic periapical assessment + success rate based on Radiographic findings
|
6 month follow up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain intensity
Time Frame: Within the first 24 hrs upto the 7th day
|
VAS used to record daily pain intensity
|
Within the first 24 hrs upto the 7th day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Geraldine Ahmed, Vice Dean of Faculty of Dentistry Cairo University
- Study Chair: Ahmed S. Elsheshtawy, Lecturer of Endodontics
- Study Chair: Ayah Abdolwahab, Lecturer of Biomaterials
- Principal Investigator: Noor K. Sayed, Resident of Endodontics
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 25, 2023
Primary Completion (Estimated)
March 1, 2024
Study Completion (Estimated)
April 1, 2024
Study Registration Dates
First Submitted
May 9, 2023
First Submitted That Met QC Criteria
May 24, 2023
First Posted (Actual)
May 25, 2023
Study Record Updates
Last Update Posted (Actual)
May 25, 2023
Last Update Submitted That Met QC Criteria
May 24, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ENDO-3-7-2
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vital Pulp Treatment in Mature Permanent Teeth With Irreversible Pulpitis
-
Nanfang Hospital of Southern Medical UniversityRecruitingIrreversible Pulpitis | Mature TeethChina
-
University of TromsoNorwegian Public dental health serviceCompletedReversible Pulpitis | Mature Teeth | Proximal Caries | Carious Exposure | Human Permanent First and Second Molars | Healthy PulpLithuania, Norway
-
Cairo UniversityNot yet recruitingMandibular Molar Teeth With Symptomatic Irreversible PulpitisEgypt
-
Cairo UniversityUnknownEvaluate Occlusal Reduction on Post-operative Pain | Teeth With Symptomatic Irreversible Pulpitis | Apical Periodontitis
Clinical Trials on Total pulpotomy with I-prf mixed with Nano-bioactive glass
-
Maharishi Markendeswar University (Deemed to be...CompletedBone Loss | Chronic Periodontitis | Intrabony Periodontal DefectIndia